These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 19246690)

  • 1. Update of the stroke therapy academic industry roundtable preclinical recommendations.
    Fisher M; Feuerstein G; Howells DW; Hurn PD; Kent TA; Savitz SI; Lo EH;
    Stroke; 2009 Jun; 40(6):2244-50. PubMed ID: 19246690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments.
    Kahle MP; Bix GJ
    Stroke Res Treat; 2012; 2012():374098. PubMed ID: 23326759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.
    Albers GW; Goldstein LB; Hess DC; Wechsler LR; Furie KL; Gorelick PB; Hurn P; Liebeskind DS; Nogueira RG; Saver JL;
    Stroke; 2011 Sep; 42(9):2645-50. PubMed ID: 21852620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.
    Fisher M; Albers GW; Donnan GA; Furlan AJ; Grotta JC; Kidwell CS; Sacco RL; Wechsler LR;
    Stroke; 2005 Aug; 36(8):1808-13. PubMed ID: 16020764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.
    Fisher M;
    Stroke; 2003 Jun; 34(6):1539-46. PubMed ID: 12750546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
    Savitz SI
    Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Stroke Therapy Academic Industry Roundtable (STAIR) Guidelines on Peri-Anesthesia Care for Rat Models of Stroke: A Meta-Analysis Comparing the Years 2005 and 2015.
    Thomas A; Detilleux J; Flecknell P; Sandersen C
    PLoS One; 2017; 12(1):e0170243. PubMed ID: 28122007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI.
    Lyden P; Buchan A; Boltze J; Fisher M;
    Stroke; 2021 Aug; 52(9):3063-3071. PubMed ID: 34289707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.
    Saver JL; Jovin TG; Smith WS; Albers GW; Baron JC; Boltze J; Broderick JP; Davis LA; Demchuk AM; DeSena S; Fiehler J; Gorelick PB; Hacke W; Holt B; Jahan R; Jing H; Khatri P; Kidwell CS; Lees KR; Lev MH; Liebeskind DS; Luby M; Lyden P; Megerian JT; Mocco J; Muir KW; Rowley HA; Ruedy RM; Savitz SI; Sipelis VJ; Shimp SK; Wechsler LR; Wintermark M; Wu O; Yavagal DR; Yoo AJ;
    Stroke; 2013 Dec; 44(12):3596-601. PubMed ID: 24193797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR; Ashwood T
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedural and Methodological Quality in Preclinical Stroke Research-A Cohort Analysis of the Rat MCAO Model Comparing Periods Before and After the Publication of STAIR/ARRIVE.
    Friedrich J; Lindauer U; Höllig A
    Front Neurol; 2022; 13():834003. PubMed ID: 35707032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results.
    Lyden PD; Bosetti F; Diniz MA; Rogatko A; Koenig JI; Lamb J; Nagarkatti KA; Cabeen RP; Hess DC; Kamat PK; Khan MB; Wood K; Dhandapani K; Arbab AS; Leira EC; Chauhan AK; Dhanesha N; Patel RB; Kumskova M; Thedens D; Morais A; Imai T; Qin T; Ayata C; Boisserand LSB; Herman AL; Beatty HE; Velazquez SE; Diaz-Perez S; Sanganahalli BG; Mihailovic JM; Hyder F; Sansing LH; Koehler RC; Lannon S; Shi Y; Karuppagounder SS; Bibic A; Akhter K; Aronowski J; McCullough LD; Chauhan A; Goh A;
    Stroke; 2022 May; 53(5):1802-1812. PubMed ID: 35354299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the translation of animal ischemic stroke studies to humans.
    Jickling GC; Sharp FR
    Metab Brain Dis; 2015 Apr; 30(2):461-7. PubMed ID: 24526567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection for stroke: current status and future perspectives.
    Minnerup J; Sutherland BA; Buchan AM; Kleinschnitz C
    Int J Mol Sci; 2012; 13(9):11753-11772. PubMed ID: 23109881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.
    Jovin TG; Albers GW; Liebeskind DS;
    Stroke; 2016 Oct; 47(10):2656-65. PubMed ID: 27586682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models: help or hindrance.
    Willing AE
    Stroke; 2009 Mar; 40(3 Suppl):S152-4. PubMed ID: 19064786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.